Sun Pharma dips 3% on profit booking post March quarter results

Shares of Sun Pharmaceutical Industries fell 3 per cent to Rs 676 on the BSE in intra-day trade on Friday as investors booked profit after the company reported a lower-than-expected profit after tax (PAT) in the March quarter (Q4F21) due to lower other income.

In the past three months, the stock outperformed the market by gaining nearly 20 per cent, as compared to 4.6 per cent rise in the S&P BSE Sensex, till Thursday.

Sun Pharma, on Thursday, posted a 124 per cent year-on-year (YoY) rise in net profit in the fourth quarter of financial year 2020-21 at